Results 131 to 140 of about 18,669 (233)

Oral Soft Tissue Biopsy in Patients Receiving Direct Oral Anticoagulants: A Prospective Cohort Study on Bleeding Outcomes

open access: yesOral Diseases, EarlyView.
ABSTRACT Background Direct oral anticoagulants (DOACs) are the first‐line therapy for stroke prevention in non‐valvular atrial fibrillation and venous thromboembolism. While evidence supports their continuation during routine dental procedures such as tooth extractions, data on oral soft tissue biopsies remain limited.
Rossana Izzetti   +3 more
wiley   +1 more source

HAEMFIX: Impact of Switching From SHL-FIX to EHL-FIX in Patients With Haemophilia B. [PDF]

open access: yesHaemophilia
Lonardi J   +11 more
europepmc   +1 more source

Determinants of Immune Tolerance Induction Outcomes in 237 Persons With Severe Hemophilia A

open access: yesEuropean Journal of Haematology, Volume 117, Issue 5, Page 1292-1300, November 2026.
ABSTRACT Immune tolerance induction (ITI) to eradicate an immune response against factor VIII (FVIII) has been used in hemophilia A (HA) with various success rates, costs, and treatment burden. The present study aimed to identify markers predictive of ITI success.
Marcus Fager Ferrari   +5 more
wiley   +1 more source

Strengthening Clinical Nurses' Research Capacity: A Scoping Review of Factors That Influence Nurses' Engagement in Clinical Research

open access: yesJournal of Clinical Nursing, Volume 35, Issue 11, Page 4582-4628, November 2026.
ABSTRACT Aim To identify and map evidence on factors that influence nurses' engagement in clinical research. Design A scoping review was conducted in accordance with the JBI methodology. Methods First, titles and abstracts of articles, then full‐text articles, were screened by two independent researchers against inclusion and exclusion criteria.
Lyndsay Jerusha Mackay   +9 more
wiley   +1 more source

Vitamin K deficiency bleeding of newborn masquerading haemophilia B. [PDF]

open access: yesSudan J Paediatr, 2020
Kumar M, Kumar S, Bajpayi S, Kumari R.
europepmc   +1 more source

Perfusion Cell Cultures: Is the Technology Worthwhile for Biopharmaceutical Production?

open access: yesChemBioEng Reviews, Volume 13, Issue 5, October 2026.
The biotechnology industry is pursuing innovation and robust production, yet many biopharmaceuticals are manufactured from batch or fed‐batch cell cultures. Perfusion processes, offering higher yields and efficiency, remain underused despite their maturity.
Francesco Iannacci, Mattia Sponchioni
wiley   +1 more source

Characteristics and Treatment Patterns of Patients with Haemophilia B Receiving Recombinant Coagulation Factor IX. [PDF]

open access: yesJ Clin Med
Park YS   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy